According to Trinity Biotech 's latest financial reports and stock price the company's current Operating Margin is -55.09%. At the end of 2021 the company had an Operating Margin of 6.68%.
Year | Operating Margin | Change |
---|---|---|
2021 | 6.68% | 5673.05% |
2020 | 0.12% | -100.45% |
2019 | -25.89% | 38.78% |
2018 | -18.66% | -46.34% |
2017 | -34.77% | -5.63% |
2016 | -36.84% | -237.04% |
2015 | 26.89% | 55.47% |
2014 | 17.29% | 53.58% |
2013 | 11.26% | -52.22% |
2012 | 23.57% | 0.87% |
2011 | 23.36% | -66.14% |
2010 | 69.01% | 515.9% |
2009 | 11.20% | -119.75% |
2008 | -56.74% | 177.42% |
2007 | -20.45% | -1350.43% |
2006 | 1.64% | -75.66% |
2005 | 6.72% | -6.44% |
2004 | 7.18% | -51.22% |
2003 | 14.72% | 18.49% |
2002 | 12.42% | 111.22% |
2001 | 5.88% |
Company | Operating Margin | Operating Margin differencediff. | Country |
---|---|---|---|
Abbott Laboratories ABT | 15.60% | -128.32% | ๐บ๐ธ USA |
Thermo Fisher Scientific TMO | 14.17% | -125.72% | ๐บ๐ธ USA |
Danaher DHR | 26.34% | -147.81% | ๐บ๐ธ USA |
QuidelOrtho QDEL | 2.15% | -103.90% | ๐บ๐ธ USA |
OraSure Technologies OSUR | -4.25% | -92.29% | ๐บ๐ธ USA |
Chembio Diagnostics CEMI | -91.98% | 66.96% | ๐บ๐ธ USA |
Bio-Rad Laboratories BIO | -19.26% | -65.04% | ๐บ๐ธ USA |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.